Insider Transactions in Q2 2023 at Oramed Pharmaceuticals Inc. (ORMP)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2023
|
David Silberman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,500
+9.63%
|
-
|
|
May 26
2023
|
Joshua Hexter COO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+8.22%
|
-
|
|
May 26
2023
|
Netanel Derovan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+12.06%
|
-
|
|
May 26
2023
|
Miriam Kidron Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,500
+10.26%
|
-
|
|
May 26
2023
|
Nadav Kidron President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+7.63%
|
-
|
|
May 01
2023
|
Benjamin Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Apr 17
2023
|
Arie Mayer Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+34.56%
|
-
|
|
Apr 17
2023
|
David Silberman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
97,500
+32.18%
|
-
|
|
Apr 17
2023
|
Miriam Kidron Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
213,000
+33.94%
|
-
|
|
Apr 17
2023
|
Yadin Rozov Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+20.48%
|
-
|
|
Apr 17
2023
|
Nadav Kidron President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
279,000
+17.32%
|
-
|
|
Apr 17
2023
|
Joshua Hexter COO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
108,000
+28.25%
|
-
|
|
Apr 17
2023
|
Netanel Derovan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
81,000
+38.57%
|
-
|
|
Apr 17
2023
|
Leonard Sank Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+33.82%
|
-
|
|
Apr 04
2023
|
Arie Mayer Director |
BUY
Open market or private purchase
|
Direct |
3,800
+12.41%
|
$7,600
$2.21 P/Share
|
|
Apr 03
2023
|
Arie Mayer Director |
BUY
Open market or private purchase
|
Direct |
5,009
+17.88%
|
$10,018
$2.22 P/Share
|